Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,894,452
  • Shares Outstanding, K 58,711
  • Annual Sales, $ 94,390 K
  • Annual Income, $ -346,030 K
  • 60-Month Beta 2.22
  • Price/Sales 30.17
  • Price/Cash Flow N/A
  • Price/Book 4.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -1.73
  • Number of Estimates 6
  • High Estimate -1.59
  • Low Estimate -1.91
  • Prior Year -1.19
  • Growth Rate Est. (year over year) -45.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.58 +7.32%
on 07/08/19
53.43 -12.46%
on 06/20/19
-4.65 (-9.04%)
since 06/19/19
3-Month
43.58 +7.32%
on 07/08/19
59.53 -21.43%
on 04/23/19
-9.20 (-16.44%)
since 04/18/19
52-Week
41.63 +12.35%
on 12/24/18
94.39 -50.45%
on 07/20/18
-44.41 (-48.71%)
since 07/19/18

Most Recent Stories

More News
Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference call and live...

AGIO : 46.77 (-5.13%)
Relatively Good Performance Detected in Shares of Agios Pharmaceut in the Biotechnology Industry (AGIO , RTRX , ACOR , RARE , FOLD )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AGIO : 46.77 (-5.13%)
ACOR : 6.90 (+0.15%)
RTRX : 21.21 (-0.84%)
After Yesterday's Decline of 3.87%, Agios Pharmaceut Offers Investors Better Value

Agios Pharmaceut (NASDAQ:AGIO) traded in a range yesterday that spanned from a low of $44.02 to a high of $45.37. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of...

AGIO : 46.77 (-5.13%)
Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, International

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the appointment of Orlando Oliveira to the role of senior...

AGIO : 46.77 (-5.13%)
Agios Pharmaceut Set to Possibly Rebound After Yesterday's Selloff of 3.03%

Agios Pharmaceut (NASDAQ:AGIO) traded in a range yesterday that spanned from a low of $48.81 to a high of $50.63. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of...

AGIO : 46.77 (-5.13%)
Agios Pharmaceut Shares Down 21.5% Since SmarTrend's Sell Call (AGIO)

SmarTrend identified a Downtrend for Agios Pharmaceut (NASDAQ:AGIO) on March 25th, 2019 at $61.98. In approximately 2 months, Agios Pharmaceut has returned 21.45% as of today's recent price of $48.68....

AGIO : 46.77 (-5.13%)
Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019

- Search Initiated for Company's Next Chief Scientific Officer -

AGIO : 46.77 (-5.13%)
Agios Pharmaceuticals (AGIO) Down 8% Since Last Earnings Report: Can It Rebound?

Agios Pharmaceuticals (AGIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AGIO : 46.77 (-5.13%)
Interesting AGIO Put And Call Options For July 19th

Investors in Agios Pharmaceuticals Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGIO options...

AGIO : 46.77 (-5.13%)
Walmart and Cisco rise while Virtusa and Farfetch stumble

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:

FTCH : 21.20 (-0.47%)
KEM : 19.31 (+1.74%)
AGIO : 46.77 (-5.13%)
VRTU : 43.83 (-1.39%)
FLO : 23.49 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AGIO with:

Business Summary

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts....

See More

Key Turning Points

2nd Resistance Point 50.47
1st Resistance Point 48.62
Last Price 46.77
1st Support Level 45.72
2nd Support Level 44.67

See More

52-Week High 94.39
Fibonacci 61.8% 74.24
Fibonacci 50% 68.01
Fibonacci 38.2% 61.78
Last Price 46.77
52-Week Low 41.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar